Site icon Syngene International Ltd

Preparation and in-vitro ADME assays screening for rac-Rotigotine prodrugs towards alleviating PD/restless leg syndrome

Learn how Syngene customized ADME assays to identify rac-Rotigotine prodrugs with enhanced bioavailability, which could be used for treating Parkinson’s disease and restless leg syndrome.

Exit mobile version